-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: June 2011
That Elusive Factor
Thanks Brady Huggett at Trade Secrets for this great recap of Day 1 of the 2011 BIO International Convention! Day 1 of the BIO convention. The Walter E Washington Convention Center is a huge thing, split into two sections. Panel sessions run on both sides, and the exhibition hall (opening Tuesday) is below ground, spanning some great distance underneath it all. There are hundreds of rooms and people scurrying all over, yet I spent my first Read More >
Docs at BIO: Patent Litigation Tactics and Strategies for Biosimilars
One of the highlights of the afternoon sessions at the BIO International Convention was a seminar appropriately entitled “A Brave New World: Patent Litigation Tactics and Strategies for Biosimilars,” where an experienced panel of patent attorneys presented their interpretation of the new biosimilars pathway of the Biologics Price Competition and Innovation Act and speculated on some of the potential issues that will arise once the statute is put into practice. From Patent Docs.
Tony Blair Talks Biotech
From Snapshot At Monday’s keynote luncheon, former British Prime Minister Tony Blair was quizzed about his motives for seeking office and his feelings about the criticism he received for allying with former President Bush. Interesting, but just as I was beginning to wonder if Blair would comment on the biotech industry, he did. Succinctly and with British understatement. When BIO president Jim Greenwood asked how Blair saw the role of government in advancing biotech, he Read More >
2011 BIO International Convention: Talent is Talent
From Trade Secrets Even if the total numbers of attendees at BIO is down from its peak, it’s still an incredibly large gathering of diverse people across the biotech spectrum. The exhibit hall is a good reflection of that. I can remember when the hall was just a collection of simple individual company stands – a few employees in a booth, a poster hanging behind them. But as the industry grew, the exhibitors changed; the Read More >
Perspectives from Brazil, India, Argentina, and South Africa
From PharmaTech Talk At this week’s Partnering for Global Health Forum, sponsored by BIO and BioVentures for Global Health, in Washington, DC, a unique panel of government leaders from emerging markets discussed what it takes to do business in their countries. Among the panelists were: Argentina’s Lino Barañao, Minister of Science, Technology and Innovative Production; India’s Maharaj K. Bhan, Secretary, Department of Biotechnology; South Africa’s Bongi Gumede, Senior General Manager, Technology Innovation and Marketing, Technology Read More >
